Showing results (361-370 of 661) with videos related to

Sort By:
Pageof 67
Journal of Public Health (Oxford, England)|July 14, 2012
Monitoring the use and outcomes of new devices and procedures: how does coding affect what Hospital Episode Statistics contribute? Lessons from 12 emerging procedures 2006-10Hannah Patrick, Andrew Sims, Julie Burn, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancerTamas Hickish, Jim Cassidy, David Propper, et al.
Cancers|January 26, 2024
Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal AdenocarcinomaKai Tai Derek Yeung, Joseph Doyle, Sacheen Kumar, et al.
Gut|August 10, 2017
Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II studyKhurum Khan, Mihaela Rata, David Cunningham, et al.
Expert Review of Anticancer Therapy|March 19, 2020
Update on optimal treatment for metastatic colorectal cancer from the AGITG expert meeting: ESMO congress 2019David K Lau, Matthew Burge, Amitesh Roy, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 25, 2019
Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancerIan Chau, Dung T Le, Patrick A Ott, et al.
The Oncologist|June 2, 2018
Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open-Label, Phase I Trial (JVDF)Hendrik-Tobias Arkenau, Juan Martin-Liberal, Emiliano Calvo, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 4, 2019
Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancerIan Chau, Dung T Le, Patrick A Ott, et al.
Medical Oncology (Northwood, London, England)|August 24, 2014
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patientsVincenzo Formica, Jessica Luccchetti, David Cunningham, et al.
BMJ Open|May 13, 2022
'It's the empathy'-defining a role for peer support among people living with chronic kidney disease: a qualitative studyMeghan J Elliott, Shannan Love, Danielle E Fox, et al.
Pageof 67